Apollomics (APLMW) Competitors $0.01 +0.00 (+27.06%) As of 04/1/2025 03:22 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrendsBuy This Stock APLMW vs. ATNFW, SXTPW, DRTSW, WENAW, BCTXW, CDIOW, CTCXW, CELUW, CEROW, and CINGWShould you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry. Apollomics vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics Cingulate 180 Life Sciences (NASDAQ:ATNFW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability, media sentiment and community ranking. Is ATNFW or APLMW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Apollomics N/A N/A N/A Does the media refer more to ATNFW or APLMW? In the previous week, Apollomics had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Apollomics and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat Apollomics' score of 0.29 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Very Positive Apollomics Neutral Does the MarketBeat Community prefer ATNFW or APLMW? 180 Life Sciences and Apollomics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AApollomicsN/AN/A Which has better earnings & valuation, ATNFW or APLMW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AApollomicsN/AN/AN/AN/AN/A Summary180 Life Sciences and Apollomics tied by winning 1 of the 2 factors compared between the two stocks. Remove Ads Get Apollomics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLMW vs. The Competition Export to ExcelMetricApollomicsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$114.86M$5.54B$7.86BDividend YieldN/A3.69%5.35%4.04%P/E RatioN/A3.1323.4018.67Price / SalesN/A4,162.83369.3087.31Price / CashN/A13.0138.1634.64Price / BookN/A35.496.624.09Net IncomeN/A-$87.82M$3.20B$246.93M7 Day PerformanceN/A-4.33%-5.00%-3.16%1 Month PerformanceN/A57.65%-1.57%-6.74%1 Year PerformanceN/A86.06%8.66%-0.49% Apollomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLMWApollomicsN/A$0.01+27.1%N/A-63.9%$0.00N/A0.0059Short Interest ↑ATNFW180 Life SciencesN/A$0.01-12.5%N/A-14.6%$0.00N/A0.007Positive NewsGap DownHigh Trading VolumeSXTPW60 Degrees PharmaceuticalsN/A$0.02-0.9%N/A-74.3%$0.00$502,409.000.002Positive NewsDRTSWAlpha Tau MedicalN/A$0.22-7.4%N/A-12.0%$0.00N/A0.0080Gap DownHigh Trading VolumeWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.09-10.9%N/A-92.6%$0.00N/A0.008Positive NewsGap DownCDIOWCardio DiagnosticsN/A$0.04-1.8%N/A-57.7%$0.00$34,890.000.007Gap DownCTCXWCarmellN/A$0.03+6.8%N/A-83.7%$0.00$32,839.000.0014Positive NewsGap UpCELUWCelularityN/A$0.04+2.5%N/A-11.6%$0.00$48.20M0.00220Positive NewsGap UpCEROWCERo TherapeuticsN/A$0.01-12.4%N/A-88.2%$0.00N/A0.008Gap DownCINGWCingulateN/A$0.05+0.2%N/A+137.4%$0.00N/A0.0020 Remove Ads Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives WENAW Alternatives BCTXW Alternatives CDIOW Alternatives CTCXW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLMW) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
